India · Delayed Price · Currency is INR Jenburkt Pharmaceuticals Company Description
Jenburkt Pharmaceuticals Limited manufactures and markets pharmaceutical formulations in India and internationally.
The company offers therapeutic solutions, such as analgesic and antipyretics, anthelmintics, anti-arthritic, anti-diabetics, anti-infectives, antifungals, antimalarials, antiulcerants and antacids, aphrodisiac, atopic dermatitis, consumer division, cough and cold, muscle relaxants, neuropathic pain, nutraceuticals, and pain management.
It offers its products under the Allerzine, CartiSafe Forte, Crisbo, Eberjen, ECOPROT, Frendacid, Fundu, Glajen-E, GLUCOTROL, HYBRITA, Jenflam, La-Viril, LUMA, Lubtriben, Metmin, Nervega-75, Nervijen P, Nervijen, NOCAL, Numox-625, OJEN, ORNEL, Oxicojen, PANTAZOLE, PIRITEXYL, POWERDOL, Powergesic, Rabera, Topcal-M, Trapidol-D, TREGA, TRIBEN, ZENGLOBIN, ZIX, Zix-MR, Zix-PG 200/75, and Zydol Suspension brand names.
The company also exports its products. It serves large government, semi-government institutions, missionary hospitals, and public sector enterprises.
Jenburkt Pharmaceuticals Limited was incorporated in 1985 and is based in Mumbai, India.
| Country | India |
| Founded | 1985 |
| Industry | Pharmaceutical Preparations |
| Employees | 801 |
| CEO | Ashish Bhuta |
Contact Details
Address: Nirmala Apartments Mumbai, Maharashtra 400058 India | |
| Phone | 91 22 6760 3603 |
| Website | jenburkt.com |
Stock Details
| Ticker Symbol | 524731 |
| Exchange | Bombay Stock Exchange |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Ashish Bhuta | Chief Executive Officer |
| Dilip Bhuta | Chief Financial Officer |